Surveillance of Humira Injection in Korean Patients

Inclusion Criteria

• •Adult patients (19 years and above) with one of the following indications:
• •* Moderately to severely active rheumatoid arthritis or
• •* active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate or
• •* severe active ankylosing spondylitis who have had an inadequate response to conventional therapy or
• •* severely active Crohn's disease who have had no response, intolerance or contraindication to corticosteroid therapy or immunosuppressants or
• •* moderately to severely active psoriasis patients who have had no response, have intolerance or have contraindication to systemic therapies including cyclosporine, methotrexate or photochemotherapy (PUVA).
• •Patients who give verbal or written authorization to use their personal and health data.